During the corresponding time, Ekso Bionics Holdings Inc saw a revenue deteriorated by -26.09 % year on year, sequentially revenue fell by -43.5 %. While revenue at the Ekso Bionics Holdings Inc 's corporate clients
Ekso Bionics Holdings Inc's Comment on Sales, Marketing and Customers
The company operates two business segments: the Cloud Business and the Legacy Ekso Business. The Cloud Business provides colocation services at third-party data centers in Colorado, Minnesota, and Utah, serving customers including artificial intelligence and machine learning developers. These customers pay a fixed rate for energized space supported by the company's equipment. The Legacy Ekso Business designs, develops, and markets exoskeleton and related products aimed at augmenting human strength, endurance, and mobility. The Board has committed to divesting the Legacy Ekso Business to focus exclusively on the Cloud Business, with the divestiture expected to be completed in fiscal year 2027. Notable customers include the Veterans Administration.
Advancing Rehabilitation Technology: Ekso Bionics and Shepherd Center Form Research PartnershipIn a bid to revolutionize rehabilitation and enhance patient outcomes, Ekso Bionics, a leading developer of exoskeleton technology, has announced a promising research partnership with the renowned Shepherd Center. The collaboration aims to expand the use of EksoNR and Ekso Indego devices in both rehabilitation and community settings, heralding a new era in patient care. This article will delve into the details of this exciting partnership and explore its potential for improving patient quality of life.Enhanced Rehabilitation Possibilities:The partnership between Ekso Bionics and Shepherd Center signifies a signific...
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare and Medicaid Services (CMS) for Ekso Indego PersonalSAN RAFAEL, Calif., April 12, 2024 - Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading provider of exoskeleton technology for medical and industrial applications, is pleased to announce a significant milestone in its mission to improve mobility and quality of life for individuals with spinal cord injuries. The Centers for Medicare and Medicaid Services (CMS) has reached a final payment determination for Medicare reimbursement of the Ekso Indego Personal exoskeleton.The Pricing, Data Analysis, and Coding (PDAC) contractor for the CMS has established...
Ekso Bionics Holdings Inc’s Comment on Sales, Marketing and Customers
The company operates two business segments: the Cloud Business and the Legacy Ekso Business. The Cloud Business provides colocation services at third-party data centers in Colorado, Minnesota, and Utah, serving customers including artificial intelligence and machine learning developers. These customers pay a fixed rate for energized space supported by the company's equipment. The Legacy Ekso Business designs, develops, and markets exoskeleton and related products aimed at augmenting human strength, endurance, and mobility. The Board has committed to divesting the Legacy Ekso Business to focus exclusively on the Cloud Business, with the divestiture expected to be completed in fiscal year 2027. Notable customers include the Veterans Administration.
Sources:
Ekso Bionics Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Ekso Bionics Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on Ekso Bionics Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
64.8 %